BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Coluccio C, Begini P, Marzano A, Pellicelli A, Imperatrice B, Anania G, Delle Fave G, Marignani M. Hepatitis B in patients with hematological diseases: An update. World J Hepatol 2017; 9(25): 1043-1053 [PMID: 28951776 DOI: 10.4254/wjh.v9.i25.1043]
URL: https://www.wjgnet.com/1948-5182/full/v9/i25/1043.htm
Number Citing Articles
Chaoyu Wang, Bing Xia, Qiaoyang Ning, Haifeng Zhao, Hongliang Yang, Zhigang Zhao, Xiaofang Wang, Yafei Wang, Yong Yu, Yizhuo Zhang. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in ChinaAnnals of Hematology 2018; 97(3): 453 doi: 10.1007/s00277-017-3188-2
Arturo Ciccullo, F. R. Ponziani, E. Maiolo, F. Pallavicini, M. Pompili. Late reactivation of hepatitis B virus after rituximab-containing chemotherapy for mantle cell lymphoma: a case reportInfection 2019; 47(2): 313 doi: 10.1007/s15010-018-1242-1
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its preventionWorld Journal of Gastroenterology 2019; 25(26): 3299-3312 doi: 10.3748/wjg.v25.i26.3299
Dao-guang Chen, Gang Chen, Chang Wang, Long-feng Ke, Hui Wu, Hong-ming He, Yu Yang, Yan-ping Chen. Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in ChinaInfectious Agents and Cancer 2021; 16(1) doi: 10.1186/s13027-021-00396-x
Claudia Giordano, Marco Picardi, Novella Pugliese, Annamaria Vincenzi, Davide Pio Abagnale, Laura De Fazio, Maria Luisa Giannattasio, Carmina Fatigati, Mauro Ciriello, Alessia Salemme, Giada Muccioli Casadei, Elena Vigliar, Massimo Mascolo, Giancarlo Troncone, Fabrizio Pane. Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1130899
Lan-Ying He, Yu-Lan Wang, Xu Tian, Wei-Qing Chen. The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapyMedicine 2020; 99(14): e19647 doi: 10.1097/MD.0000000000019647
Xing Cao, Yafei Wang, Panyun Li, Wei Huang, Xiaojuan Lu, Hongda Lu. HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management StrategiesFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.685706
Ibrahim M. Sayed, Mohamed Ismail Seddik, Marwa A. Gaber, Saber H. Saber, Sahar A. Mandour, Mohamed A. El-Mokhtar. Replication of Hepatitis E Virus (HEV) in Primary Human-Derived Monocytes and Macrophages In VitroVaccines 2020; 8(2): 239 doi: 10.3390/vaccines8020239
Gonçalo Pereira Cruz, Celene Sargento, Maria Conceição Ventura, Joaquim Oliveira, José Saraiva da Cunha. Occult hepatitis B infection by a recombinant D/C virus in an immunosuppressed patientIDCases 2020; 19: e00671 doi: 10.1016/j.idcr.2019.e00671
Hongming Nie, Zhaohe Mei, Rong Wang, Binbin Zhao, Yueqiu Gao, Jianjie Chen, Lingtai Wang. Bushen recipe and its disassembled prescriptions inhibit inflammation of liver injury associated with Concanavalin A through Toll‑like receptor 3/9 signaling pathwayMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.9082
Anna H. Schuh, Nilima Parry‐Jones, Niamh Appleby, Adrian Bloor, Claire E. Dearden, Christopher Fegan, George Follows, Christopher P. Fox, Sunil Iyengar, Ben Kennedy, Helen McCarthy, Helen M. Parry, Piers Patten, Andrew R. Pettitt, Ingo Ringshausen, Renata Walewska, Peter Hillmen. Guideline for the treatment of chronic lymphocytic leukaemiaBritish Journal of Haematology 2018; 182(3): 344 doi: 10.1111/bjh.15460
Man-Fung Yuen, Ding-Shinn Chen, Geoffrey M. Dusheiko, Harry L. A. Janssen, Daryl T. Y. Lau, Stephen A. Locarnini, Marion G. Peters, Ching-Lung Lai. Hepatitis B virus infectionNature Reviews Disease Primers 2018; 4(1) doi: 10.1038/nrdp.2018.35
Alessandra Zannella, Massimo Marignani, Paola Begini. Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical ManagementViruses 2019; 11(9): 858 doi: 10.3390/v11090858